Entering text into the input field will update the search result below

Achilles Therapeutics: The First Full Position In My Tax Loss Selling Basket

Amit Ghate profile picture
Amit Ghate


  • ACHL has about $4.40 of cash per share on hand, yet it trades below $1.
  • I believe that recent selling is due to tax loss sellers needing to recognize capital loss before the end of the year, and hence their selling is indiscriminate.
  • I profile the company as well as further explaining my tax loss buying strategy.

The 2020 TAX TIME note is on the hundred dollar bill. Tax concept

turk_stock_photographer/iStock via Getty Images

Tax Loss Strategy

As I discussed in a previous article, I'm beginning to accumulate a basket of stocks that are selling off near year end as investors try to realize capital losses to offset any

$0.25 to $1 stocks

Seeking Alpha screener

$0.25 to $5 stocks

Seeking Alpha screener

2 year chart


3 month chart


clonal neoantigens

April corporate presentation


April corporate presentation


company website

pretreatment and safety

December presentation


December presentation


December presentation

ACHL Balance Sheet


Quant Rating

Seeking Alpha

This article was written by

Amit Ghate profile picture
I'm a private trader interested in both long and short ideas. My training and background are in engineering including several decades of consulting engineering practice. I endeavor to apply my analytical skills to investing/trading, which I've done for 20+ years and to which I bring a contrarian style. I've also recently become interested in writing and have published editorials at Forbes, PJM, and a few legacy newspapers.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of ACHL IFRX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

I actively trade around core positions.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.